Identifying patients with rheumatoid arthritis with moderate disease activity at risk of significant radiographic progression despite methotrexate treatment

OBJECTIVES: To determine the baseline factors predictive of significant radiographic progression (SRP) in patients with moderately active rheumatoid arthritis (RA) despite receiving methotrexate (MTX). METHODS: Patients from the MTX arm of the Trial of Etanercept and Methotrexate with Radiographic P...

Descripción completa

Detalles Bibliográficos
Autores principales: Fautrel, B, Nab, H W, Brault, Y, Gallo, G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2015
Materias:
Rheumatoid Arthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4613151/
https://www.ncbi.nlm.nih.gov/pubmed/26509051
http://dx.doi.org/10.1136/rmdopen-2014-000018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4613151/
https://www.ncbi.nlm.nih.gov/pubmed/26509051
http://dx.doi.org/10.1136/rmdopen-2014-000018

Ejemplares similares